In the Journals

Frequent coffee, chocolate consumption reduced liver enzymes in HIV/HCV coinfected patients

August 29, 2013
Patients coinfected with HIV and HCV who reported eating chocolate daily and drinking three or more cups of coffee a day had lower levels of ALT and…
Pharmacology Consult

New protease inhibitors showing promise for HIV/HCV coinfection

August 28, 2013
This is an exciting time in the treatment of chronic hepatitis C virus infections. As opposed to the antibiotic pipeline, there are a number of new…
In the Journals

Mental, physical health, fatigue worsened by antiviral therapy, anemia in HCV

August 21, 2013
Patients with chronic hepatitis C, particularly those with anemia, experienced significantly impaired mental and physical health and worsened fatigue…
In the Journals

Hepascore predictive of mortality, morbidity in chronic HCV

August 20, 2013
Hepascore, a noninvasive measurement of liver fibrosis, was similarly accurate to liver biopsy in predicting mortality and liver-related morbidity…
In the Journals

Presence of HCV symptoms reason for testing in almost half of infected patients

August 19, 2013
Nearly half of adults infected with hepatitis C sought testing only after experiencing the clinical indications of liver disease, according to the…
In the Journals

Faldaprevir/deleobuvir combination, with ribavirin, effective for chronic HCV

August 16, 2013
An interferon-free regimen of faldaprevir, deleobuvir and ribavirin effectively treated patients with chronic hepatitis C genotype 1 in a recent…
In the Journals

Absolute lymphocyte count predictive of HCV recurrence post-liver transplant

August 15, 2013
Liver transplant recipients with HCV and lymphopenia had poorer survival and a greater risk for recurrence than patients with higher absolute…
In the Journals

Advanced fibrosis raised risk for decompensation in HIV/HCV coinfection

August 15, 2013
Hepatitis C therapy is necessary in patients with advanced fibrosis who are coinfected with hepatitis C and HIV because they are at risk for liver…

Phase 3 trial assessing therapy for post-liver transplant HCV initiated

August 8, 2013
Biotest AG has initiated treatment in a phase 3 clinical trial in North America of a therapy for patients who require liver transplantation because…
In the Journals

Telaprevir safe, effective among older patients with chronic HCV

July 30, 2013
Advanced age did not impact the efficacy of triple therapy with pegylated interferon, ribavirin and telaprevir among patients with hepatitis C…